Introduction
Sialic acids (Sias) are nine-carbon electro-negatively charged monosaccharides commonlyf ound on deuterostome cell-surface glycoconjugates. [1] Because of their position, charge, and structurald iversity,t hey are of particulari mportance in modulating av ariety of cellular recognition events. [2] In human tissue, the most common is N-acetyl-neuraminic acid (5-acetamido-3,5-dideoxy-d-glycero-d-galacto-nonulopyranos-1-onic acid, Neu5Ac). In vivo, it is synthesized from N-acetyl mannosamine (ManNAc) or N-acetyl glucosamine (GlcNAc) alonga complexm etabolic pathway. [3] Indeed, sialica cids metabolism requires av ariety of enzymes at differents ubcellular sites of mammalian cells;a mong these are the nuclear CMP-Neu5Ac synthase( CSS or CMAS), the cytosolicU DP-GlcNAc 2-epimerase/N-acetylmannosamine kinase (GNE),t he cytosolicc ytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMAH), the Golgi CMP-Neu5Ac transporter (SLC35A1),2 0G olgi sialyltransferases (STs), and four sialidases (Neus). [3] With the advent of chemical biology, new metabolic glycoengineering methodologies,M OE (metabolic oligosaccharide engineering) or MGE (metabolic glycoengineering), have arisen to study sialic acid metabolic pathways in eukaryotes. These ground-breaking strategies, pioneered by the groups of Reutter [4] and Bertozzi [5] hijack cell metabolism by the introduction of an unnatural monosaccharide bearingachemical modification. From this startingp oint, two main approaches have emerged. First, chemicalm odificationso fM anNAc, such as elongation of the N-acyls ide chain of peracetylated monosaccharides (largely used by the Reutter and Hortskorte groups), has led to the discoveryo fi mportanta nd unexpected functions of the N-acyl side chain of sialic acids, such as modulation of virus binding, stimulation of neuralc ell growth, and activationo fTlymphocytes.
[6] The second approach, initially developed by the Bertozzi group, consists of specific covalent ligationo faspecific probe to ac hemical reporter,t hrough universal bioorthogonal chemicalr eactions (click chemistry). [7] Many bioorthogonal strategies have been reported, such as Staudinger-Bertozzi, [8] copperc atalyzed alkyne-azide cycloaddition (CuAAC), [9] strainpromoted alkyne-azide cycloaddition (SPAAC), [10] and DielsAlder reactions with inverse electronic demand (DAinv). [11] These fast-growings trategies reflectt he development of chemicalt ools for biological issues, and the associated new instruments for bio-imaging are essential to shed light on the metabolic pathways of sialic acid.
However,t hese MOE approaches are hindered by the inefficient use of monosaccharide analoguesa nd somewhat limited by variability among cell lines in incorporating these unnatural sialic acids. To overcome these limitations, fluorescenta nd photoactivable cytidine-5'-monophospho-sialic acids (CMPSialylationo fg lycoproteins and glycolipids is catalyzed by sialyltransferases in the Golgi of mammalian cells, whereby sialic acid residues are added at the nonreducing ends of oligosaccharides.B ecause sialylated glycansp lay critical roles in an umber of human physio-pathological processes, the past two decades have witnessed the development of modifieds ialica cid derivatives for ab etter understanding of sialic acid biology and for the development of new therapeutic targets. However, nothingi sk nown about how individual mammalian sialyltransferasestolerate and behave towards these unnatural CMP-sialic acid donors. In this study,w ed evised several approaches to investigate the donor specificity of the human b-d-galactoside sialyltransferases ST6Gal Ia nd ST3Gal Ib yu sing two CMP-sialic acids:C MP-Neu5Ac, and CMP-Neu5N-(4pentynoyl)neuraminic acid (CMP-SiaNAl), an unnatural CMP-sialic acid donor with an extended and functionalized N-acyl moiety.
[a] M. Noel, P. -A. Gilormini Sias) [12] and CMP-Neu5N-acyl derivatives, [13] which can be covalently attached to asialoglycoconjugates, were synthesized. As these CMP-Sias analoguesa re not membrane-permeable (thus limiting their use in living cells), selective exo-enzymaticl abeling (SEEL) for the eukaryotic cell surface was developed by using exogenousr ecombinant rat b-galactoside (a2,6-sialyltransferase ST6Gal I) and C-5 or C-9 azido-modified CMP-Sias to labelc ell-surface N-linked glycans. [14] This approachw as successfully used to achieve profiling of the cell-surface glycoproteome. [15] Moreover, an euraminidase-coupledS EELs trategy with specific sialyltransferases led to the efficient labeling and detection of sialylated N-and O-glycosylproteins by mass spectrometry. [16] Thus, the main advantage of SEEL over MOE is selective labeling of glycanso nt he cell surface without interfering with endogenous enzymes of the sialic acid pathway.I n addition, SEEL offersapromising new strategy for the study of recombinant sialyltransferases and in particular of their tolerance towardd ifferent donor/acceptor substrates directly at the cell surface.
Sialyltransferases are key evolutionarily conserved enzymes involved in the final steps of the sialic acid pathway;t hey catalyze the transfer of sialic acid residues from an activated CMPSia donor onto galactose (Gal), N-acetylgalactosamine (GalNAc), or another sialic acid residue of glycoproteinso rg lycolipids. [17] The twentyi dentified human sialyltransferases are classified into four families:S T6Gal, ST3Gal, ST8Sia, andS T6Gal-NAc (named according to the monosaccharide acceptor and glycosidicl inkagef ormed).
[18] Molecular cloning and biochemical characterization are availablef or al imited number of mammalian sialyltransferases, and despite the increasingn umber of crystal structures of these enzymes, [19] our understanding of their structure/activity relationships is still very limited. Several studies have underscored their exquisite acceptors ubstrate specificity,l ikely relyingo ns pecific sequence motifs ("sialylmotifs") [20] and their redundant activity in vivo.
Af ew studies have reported the sialylation kinetics of mammalian sialyltransferases with various exogenous glycoprotein substrates.
[21] However,a lmost nothing is known about how individualm ammalians ialyltransferases behavet owardsC MPSias donors and how these glycosyltransferases tolerate natural and unnatural sialic acids. It is interesting to note that the evolutionarily relatedm ammalian polysialyltransferases ST8Sia II and ST8Sia IV [22] differentially use N-acyld erivatives of Neu5Ac, thus suggestingd iverse donors ubstrate affinities.
[6c, 23] In order to address this question, we focusedo nt he most widely knownh uman glycoprotein b-d-galactoside a2,3/6-sialyltransferases: ST6Gal Ia nd ST3Gal I. [24] These two enzymes catalyze the formation of a-2-6 or a-2-3 glycosidic linkageso nt he terminal Gal of type-II (Galb1,4GlcNAc) andt ype-III (Galb1,3Gal-NAc) disaccharides found on N-glycans and O-glycans, respectively.E ach enzyme was released into the cell culture medium of transiently transfected HEK293c ells as truncated recombinant proteins, and used either for in vitro assays or with living cells to quantitatively evaluatet he ability to use N-acyl CMPSia derivatives. For this purpose, CMP-Neu5Ac and CMP-N-(4-pentynoyl)neuraminic acid (CMP-SiaNAl) bearinga ne xtended N-acyl group functionalized with alkyne group were synthesized as previously described. [25] Results and Discussion Chemical synthesis of CMP-Sia derivatives:CMP-SiaNAl, CMP-Neu5Ac
To evaluate the donor substrate tolerance of sialyltransferases, we synthesized two activated CMP-Sia donors (Scheme 1), one natural( CMP-Neu5Ac) and one alkynyl derivative( CMP-N-(4-pentynoyl)neuraminic acid or CMP-SiaNAl) by using readily availableC MP-sialic acid synthase (E.C. 2.7.7.43) from Neisseria meningitidis as recently described. [25] Each substrate was direct- Recombinant expression of mammalian sialyltransferasesi n suitable amounts and quality is difficult, and few commercial sourceso fh uman sialyltransferases are available. As N-terminal truncation of sialyltransferases impactse nzyme production and activity, [26] we generated soluble activef orms of the human ST3Gal Ia nd ST6Gal Ie nzymes lacking the first 56 amino acids of the open reading frame (cytoplasmict ail and transmembrane and stem domains). Thee nzymesw ere named D56ST3Gal Ia nd D56ST6Gal I, respectively.AFLAG-tag and a preprotrypsin signal peptidew ere introduced into the recombinant chimericp roteins fore fficient secretion of an N-terminal FLAG-tagged recombinant enzyme into the culture mediumo ft ransiently transfected human embryonic kidney cells (HEK293). Thirty-six hours post-transfection, we detected the secreted FLAG-tagged enzymeb yw estern blotting with an anti-FLAG antibody( Figure1). D56ST3Gal Ia nd D56ST6Gal I migrateda sm ultiple bands with an apparent molecular masses of 40-50 and 54 kDa, respectively corresponding to glycosylated protein isoformsa sa ssessed by PNGase Ft reatment (data not shown). Low levels of D56ST6Gal Iw ere consistently obtained,w hereas D56ST3Gal Ie xpressed at much higher levels in the cell culture medium of transfected HEK293 cells.
Reported kinetic data forh uman sialyltransferases are sparse and vary significantly for recombinante nzymes.I nt his study, we performed enzymatic reactions for crude extracts of D56ST3Gal Ia nd D56ST6Gal Is ecreted in the HEK293 cell culture medium with freshly prepared CMP-Neu5Ac and radiolabeled CMP-[ 14 C]Neu5Ac as donor substrate, [25] and 60 mgo fd esialylated fetuin as an acceptor substrate. Fetal bovine fetuin containst hree N-glycans and three O-glycans, [27] and is commonly used as an acceptor substrate for both ST3Gal Ia nd ST6Gal I. HEK293 cells transiently transfected with an empty pFLAGp lasmid( mock) were used as an egative control, as this cell culture medium did not showa ny FLAG-tagged protein or sialyltransferase activity (Figures 1a nd 2 ). Sialylated product formation was monitored over time for each recombinant enzyme. The rate of sialylated fetuin formation remained constant for at least 5t o6 hwith either D56ST6Gal Io r D56ST3Gal I ( Figure 2A ). We also noticedt hat asialofetuin was sialylated much faster by D56ST3Gal It han by D56ST6Gal I: the Figure 1 . Production of recombinant soluble human a2,3/6-sialyltransferases D56ST6Gal Iand D56ST3GalIin the cell culture medium of HEK293 transfected cells. Truncatedi soforms (cytoplasmic tail and transmembrane domaind eleted;5 6a mino acid residues) were N-terminally tagged with FLAG. These and an empty construct (mock) were transiently expressedin HEK293c ells. After 36 h, 30 mLo fHEK293 cell culture medium was subjected to SDS-PAGE (8 %) under reducingconditions and transferred to an itrocellulose membrane. A) The membrane was stained with red ponceau, and B) western blottingwas carried out with Bio M2 anti-FLAG mAb (1/1000 e). Positions of the high-range pre-stained standards (Bio-Rad Lab) are indicated. These data are representatives of several experiments and show that D56ST3Gal Ii se xpressed at much higherl evels than D56ST6Gal Iint he culture medium, as evaluated from ImageJ analysis of the anti-FLAG signal. 14 C]Neu5Ac and6.4 mm cold CMP-Neu5Ac) donors ubstrate.P roteins were precipitated,f iltered on glass-fiberf ilters, and radioactivity was counted. B) Apparentkinetic parametersfor D56ST6Gal Iand D56ST3Gal Ic alculated for CMP-Neu5Ac. Incubationswith 10 mLoft ransfected culture medium were carried out for 6hwith various concentrations of donor substrate CMP-Neu5Ac (50 000 DPM/ 13.6 mmC MP-[
14 C]Neu5Ac and various amount of cold CMP-Neu5Ac) and 60 mgo fa sialofetuin.Proteins were precipitated, filtered on glass-fiber filters, and radioactivity was counted. The background signal (obtained withm ock) was subtracted. The dataa re mean AE SE (n = 3) and were fitted to the Michaelis-Mentenequation (fitted values AE SE in Ta ble 1). C) Enzymaticactivity towards the two CMP-Sias donors.I ncubations of 10 mLo fthe culture mediumo ft ransfected HEK293 cells containing D56ST3GalI(left) or D56ST6Gal I( right) were carriedo ut for 6hwith various concentrations (1-50 mm)o ffreshlyprepared CMP-Neu5Ac or CMP-SiaNAl and 50 000 DPM of radiolabeled CMP-[
14 C]Neu5Ac (tracer)and 60 mgo fa sialofetuin. Specific [ 14 C]Neu5Ac incorporation was calculated as described in the Experimental Section. Data are mean AE SE (n = 3). formationo fa2,3-sialylated product reached am aximum after 6h incubation, whereas the formation of a2,6-sialylatedp roduct kept on increasing up to 15 h ( Figure 2A ). We checked that our recombinant enzymes had negligible transfer activity onto potentialt argets in the medium (data not shown). We then incubated each enzymef or 6h with various concentrations of CMP-Neu5Ac (1 to 100 mm; Figure 2B ). Apparentkinetic parameters were obtainedb yn onlinearr egression analysis of the Michaelis-Menten equation in Graph Pad. The experiment was carried out three times, and the apparent K M values were determined for the donor substrate CMP-Neu5Ac as 2.79 mm (for D56ST6Gal I) and 41.23 mm (for D56ST3Gal I; Ta ble 1). These values are consistentwith those previously published. [26b, d, 28] We achieved immunoaffinity purification of each transfected cell medium (mock, ST6Gal I, and ST3Gal I)b yu sing the M2 monoclonal antibody (anti-FLAGm Ab) bound to ap rotein GSepharoser esin, with several washing steps and elution of the bound enzyme( with a3 FLAG peptide). We couldn ot obtain sufficient amount of purified ST6Gal It op erformk inetic studies. Kinetic parameters established forp urified ST3GalI were found to be similart ot hose obtained with crude enzyme, so we used the crude extracts rather than purified enzyme( data not shown).
Interestingly,i ncubations of D56ST3Gal Io rD56ST6Gal Iw ith variousc oncentrations (1-50 mm)o ff reshly preparedC MPNeu5Aco rC MP-SiaNAl and 50 000 DPM radiolabeled CMP-[ 14 C]Neu5Ac (as at racer) showed no difference( Figure 2C ). These data furthers uggested that D56ST3Gal Ia nd D56ST6Gal Ia re likely promiscuous with respectt ot he CMPSiaNAl donorc arrying an extended N-acyl group in the C5 position, as previously suggested. [4] Characterizationo ft he a2,3/6-sialyltransferase activities towards the unnatural donor substrate CMP-SiaNAl
We developed an in vitro sialyltransferase assay based on desialylatedg lycoproteins as acceptor substrates for probing D56ST3Gal Iand D56ST6Gal Isialyltransferase activities towards the unnatural sialica cid donors ubstrate CMP-SiaNAl. Sialylation reactions were carriedo ut with the cell culture medium of transfected HEK293 cells containing either D56ST3Gal Io r D56ST6Gal I( or no enzyme, mock) with 100 mm CMP-SiaNAl and 50 mgo fa cceptor substrate (fetuin, asialofetuin, or a-1-acid glycoprotein). Alpha-1-acid glycoprotein (also known as orosomucoid) contains five N-linked oligosaccharides, which are predominantly tri-and tetra-antennary structures with LacNAc structures, [29] and it is used as as pecific substrate acceptor for ST6Gal I. Following incubation, chemical ligation of azido-biotin to the transferred alkyne-sialic acid was achieved by CuAAC. Resialylated glycoproteins covalently linked to biotin wereseparated by 8% SDS-PAGE, transferred to nitrocellulose, and detectedb yw estern blotting with anti-biotin antibody.S everalb ands resulting from the D56ST6Gal Ia ctivity on asialofetuin and asialoorosomucoid could be detected (Figure 3A) , whereas no signal was detected when using fetuin as an acceptor.S imilarly, D56ST3Gal Iw as active only on asialofetuin and not on fetuin or asialoorosomucoid. As expected, PNGase Ft reatment,w hich eliminates N-glycans from resialylated fetuin, showedt hat D56ST6Gal It ransfers alkyne-sialic acid only on N-glycans; D56ST3Gal Ia ctivity was resistant to PNGase Ft reatment, thus indicating that D56ST3GalI likely transfers alkyne-sialic acid on O-glycans of asialofetuin (Figure 3B) .
To assess the efficiency of SiaNAl transfer,w eincubated each recombinant enzyme with various concentrations of CMPSiaNAl (2 to 200 mm) for 6h with 200 mgo fa sialofetuin as an acceptor ( Figure 4) . Transferred SiaNAl was released from resialylatedf etuin by acid hydrolysis and labeled with 1,2-diamino-4,5-methylenedioxybenzene (DMB). Sensitivea nd specific detectiono fD MB-coupled sialic acid was performed by LC-MS in multiple reaction monitoring (MRM)-MS 3 mode.A pparentk inetic parameters were obtainedb yn onlinearr egression analysis of the Michaelis-Menten equationi nG raph Pad ( Figure 4B ). The experiment was carriedo ut three times, and the apparent K M values for the enzymes were determined for the donor substrate CMP-SiaNAl as 6.55 mm (for D56ST6GalI;T able 2) and Cell-basedassays of a2,3/6-sialyltransferase activity By using aS EEL approach, D56ST3Gal Io rD56ST6Gal Ii nt he cell culture mediumo ft ransfected HEK293 cells was used to sialylatec ell-surface O-glycans or N-glycans with the two freshly prepared CMP-Sia derivatives, CMP-SiaNAl and CMP-Neu5Ac. Lec2 CHO cells, which are deficient in the Golgi CMP-sialic acid transporter SLC35A1, [30] were chosen to assess D56ST3Gal Ia nd D56ST6Gal Ia ctivities in vivo, as these cells express almostn o sialic acid on the cell surface. Cell-based methods including flow cytometry analysiso fc ell surfaces ialylation and confocal microscopy wereu sed to evaluate sialyltransferase activity of the recombinant enzymes with labeled lectins ( Figure 5 ). Detection of sialic acid binding wasa chievedb yu sing SNA-lectin (Sambucus nigra agglutinin, which mainly recognize a2,6-linked sialic acid of N-glycans) and MAA-lectin (Maackia amurensis agglutinin II, MAL-II, which is specific for a2,3-linked sialic acid of O-glycans). [31] We checked that CMP-Siad onors alone or cell culture medium containing no enzyme (mock)h ad no sialylation activity on Lec2 CHO cells ( Figure 5 ). The cell-surface O-glycans of the cells could not be readily labeled by D56ST3Gal Iw ith either CMP-Neu5Ac or CMP-SiaNAl substrates, thus suggesting either 1) too-lowd onor substrate concentrationsf or efficient D56ST3Gal Ia ctivity,o r2 )too-lowa cceptor substrate concentration or accessibility on Lec2 CHO cells (as suggested previously by glycomicsp rofiling studies of these cells). [32] Suitable incubation conditions for D56ST3Gal I are under study to establish efficient sialylation of O-glycans on Lec2 CHO cells. However,u sing D56ST6Gal Ic rude extract and the two CMP-Sia donor substrates, we could obtain efficient and specific sialylation of Lec2 CHO N-glycans (Figure 5A) . Interestingly,w en oticed higher fluorescencei ntensity when using the unnatural CMP-SiaNAl donor compared to CMP-Neu5Ac, regardless of concentration( Figure 5B ), thus further suggesting either more-efficient transfer of SiaNAl on cellsurfaceg lycoconjugateso rb etter recognition of the extended N-acyl group of CMP-SiaNAl by the SNA-lectin, asp reviously reported for the siglec-1 recognition of N-acyl-substituted sialic acid. [33] 
Conclusion
As af irst step towards deciphering the specificityo fd ifferent monosialyltransferases in relation to the N-acyl side chain of Nacylneuraminic acid( sialic acid), we used two b-galactoside a2,3/6-sialyltransferases,S T6Gal Ia nd ST3Gal I( specific for Nglycans and O-glycans, respectively)a nd two CMP-Sia donors, the natural donor CMP-Neu5Ac and CMP-SiaNAl (with an engineeredN -acyl side chain). We synthesized both CMP-Sia donors andp roduced soluble and active enzymes directly in the cell culture mediumo ft ransiently transfected HEK293c ells. These could be efficiently used in in vitro andi nv ivo approaches. We showed that both freshly prepared donor substratesw ere efficiently and selectively used to obtain a2,6-sialylation of N-glycans and a2,3-sialylation of O-glycans. For the first time, we investigated and compared the relative activities of these two human sialyltransferases towards naturala nd unnatural sialic acids. Additionally,wedeveloped aversatile workflow for ab etter understanding of sialylation processes. This toolbox not only provides new methods for fundamentals tudies of sialyltransferases, but also paves the way forb etter control of cell-surface glycoengineering, which is instrumental to control the behavior of cells and modulate biological recognition phenomena.
Experimental Section
General: Chemicals and reagents were purchased from Sigma-Aldrich, TCI (Zwijndrecht, Belgium), and Carbosynth (Compton, UK) and were used without further purification. The natural sialic acid analogue N-Acetylneuraminic acid (Neu5Ac) was purchased from Carbosynth;t he alkyne derivative N-(4-pentynoyl)neuraminic acid (SiaNAl) was synthesized and purified as previously described. [25, 34] Inorganic pyrophosphatase from Saccharomyces cerevisiae (EC 3.6.1.1) and CMP-sialic acid synthetase (CSS) from N. meningitidis group B( EC 2.7.7.43) were from Sigma-Aldrich. CMP-[ Cytidine-5'-monophospho-N-acetylneuraminic acid (CMPNeu5Ac) and cytidine-5'-monophospho-N-(4-pentynoyl)neuraminic acid (CMP-SiaNAl) synthesis: Activated sialic acids CMPNeu5Ac and CMP-SiaNAl were synthesized and characterized by 31 PNMR according to an optimized protocol recently reported. [25] The obtained solutions were cooled to 4 8Ca nd used in as ubsequent enzymatic sialylation assay with no further purification, or aliquoted and kept at À80 8C.
Cloning and sialyltransferases constructions;e xpression of soluble fusion sialyltransferases: cDNAs encoding at runcated form of human Galb1,3GalNAc a2,3-sialyltransferase (ST3Gal I) and Galb1,4GlcNAc a2,6-sialyltransferase (ST6Gal I) lacking the first 56 N-terminal amino acid residues were amplified by PCR by using primers (Eurogentec, Angers, France): Sense ST3Gal I: 5'-AAAAA GCTTAG GCCT TGCAC CTGCA CCCAC TG-3',a ntisense ST3Gal I: 5'-AAAGG TACCC TTCAC TGCGT CATCT CCCCT TG-3' (hD56ST3Gal I), Sense ST6Gal I( 5 '-AAAAA GCTTG GGTCT GATTC CCAGT CTG-3'), and antisense ST6Gal I( 5 '-AAAGG ATCCT TAGCA GTGAA TGGTC CGGAA G-3'). Both sense primers contained aH indIII site, and antisense primers contained aK pnI (ST3Gal I) or BamHI site (ST6Gal I) for subsequent cloning into expression vector p3xFLAG-CMV-9 (Sigma-Aldrich) as previously described.
[26d] Amplified fragments were extracted from an 0.8 %a garose gel, subcloned into the vector,a nd the final construct was checked by enzymatic digestion and sequencing.
HEK293 cells (ATCC CRL-1573) were maintained in DMEM medium (Lonza, Basel, Switzerland) complemented with fetal calf serum (10 %; Lonza) in 6-wells plates at 37 8Cu nder 5% CO 2 .C onfluent cells (70 %) were transiently transfected by using lipofectamine reagent (Invitrogen/Thermo Fisher Scientific) with ultraMEM (Lonza), by following the instruction of the manufacturer.A fter 36 h, the cell culture medium was collected, centrifuged to eliminate cell debris, and used as the crude enzyme fraction.
Sialyltransferase assays using radiolabeled CMP-[ 14 C]Neu5Ac: Assays were carried out essentially as previously described. [35] Fetuin (Sigma-Aldrich) was desialylated by using TFA( 0.1 m) for 2hat 80 8C, and free sialic acid was eliminated by using as pectra/ por3 dialysis membrane (MWCO 3500, 18 mm flat width;S pectrum Laboratories, Rancho Dominguez, CA) for 24 h. The contents were transferred to ag lass tube and lyophilized. Desialylated fetuin was suspended (20 mg mL À1 )i nw ater.A sialoorosomucoid (Sigma-Aldrich) was prepared similarly.A sialofetuin was the acceptor substrate for both ST6Gal Ia nd ST3Gal Ie nzymatic activity;a sialoorosomucoid was the acceptor substrate solely for ST6Gal I. As tandard reaction mixture (30 mL) contained cacodylate buffer (0.04 m, pH 6.2), MnCl 2 (4 mm),T riton CF-54 (0.08 %; Sigma-Aldrich), CMPSia (20 mm: CMP-[ 14 C]Neu5Ac (22.5 nCi, 50 000 DPM, 13.6 mm)a nd cold CMP-Neu5Ac (6.4 mm)), desialylated fetuin (2 mg mL À1 )a nd enzyme (10 mL). The sialylation reaction was performed with the cell culture medium of transfected HEK293 cells expressing either D56ST3Gal Io rD56ST6Gal I( or no enzyme, mock), and the mixture was incubated at 37 8Cf or 6h.T he reaction was stopped by precipitation of glycoproteins with phosphotungstic acid (PTA; 1mL, 5% in 2 n HCl) followed by filtration on Whatman GF/A glass microfiber filters. Radiolabeled sialic acid transfer onto glycoproteins was quantified by liquid scintillation counting in UltimaGold (3 mL; PerkinElmer) with aHidex 300 SL counter.
For kinetic analysis, incubations were performed with donor substrate CMP-Neu5Ac (1-100 mm) and medium (10 mL) of transfected HEK293 cells expressing either D56ST3Gal Io rD56ST6Gal I( or no enzyme, mock). As the enzyme source was the crude enzyme fraction, the kinetic parameter K M and V max are apparent constants and are named app K M and app V max .T hese values were calculated by fitting the data to the Michaelis-Menten equation that describes enzyme activity in Prism 5( GraphPad, La Jolla, CA).
SDS-PAGE and western blot analysis:
In order to check the production of sialyltransferases from the transfected HEK293 cells, culture medium (30 mL) was boiled with 4 Laemmli solution (10 mL; Tris·HCl (235 mm,p H6.8), SDS (8 %), glycerol (40 %), 2-mercaptoethanol (10 %), Bromophenol Blue (0.01 %)) for 10 min at 95 8C, then separated in an 8% polyacrylamide gel and transferred to an itrocellulose membrane. Ponceau staining was used as al oading control. Then, the membrane was saturated in blocking buffer (non-fat milk (5 %) in TBST with Tween 20 (0.05 %)) for an hour and incubated overnight at 4 8Cw ith anti-flag antibody (4 mgmL À1 ;S igma-Aldrich). After three TBST washing, the membrane was incubated with peroxidase-conjugated anti-mouse IgG antibody (1/10 000;G E Healthcare). The signal was detected by using the chemiluminescent reagent ECL 2( Thermo Fisher Scientific) and ac hemiluminescence fusion camera (Vilber Lourmat, Marne-la-VallØe, France).
To visualize enzymatic activity of the recombinant sialyltransferases D56ST3Gal Io rD56ST6Gal Io nt he various glycoprotein acceptors using the unnatural sialic acid donor CMP-SiaNAl, we set up awestern blot approach. Sialylation reactions were performed with 8.5 mLo ft he culture medium of transfected HEK293 cells expressing either recombinant D56ST3Gal Io rD56ST6Gal I( or no enzyme, mock) for 4h with freshly prepared CMP-SiaNAl (100 mm) and glycoprotein acceptor (50 mg; fetuin, asialofetuin, asialoorosomucoid or no exogenous acceptor). Following sialylation reaction, click chemistry was used to covalently link the alkyne moiety with azide-PEG3-biotin (Sigma-Aldrich). Briefly,s ialylated glycoprotein (20 mg) was incubated for 1hat 25 8Cw ith CuSO 4 (11.25 mm),2 -(4-((bis ((1-tert-butyl-1H-1,2,3 -triazol-4-yl)methyl)amino)methyl)-1H-1,2,3-triazol-1-yl)acetic acid (77.5 mm),a zido-biotin (6.96 mm; Sigma-Aldrich), and sodium ascorbate (61.88 mm) in PBS (20 mL). After click chemistry,t he glycoprotein (20 mg) was boiled for 5min in Laemmli solution. Samples were then resolved in an 8% polyacrylamide gel, transferred to an itrocellulose membrane, and ponceau staining was performed to check transfer and control loading. The membrane was saturated in blocking buffer for 1h,t hen incubated for 1h with peroxidase-conjugated IgG fraction monoclonal mouse anti-biotin (16 ng mL À1 ;J ackson Immunoresearch). After three TBST washing, the signal was detected by chemiluminescent reagent (SuperSignal West Femto Maximum Sensitivity Substrate; Thermo Fisher Scientific) and ac hemiluminescence fusion camera (Vilber Lourmat).
To assess the specificity of the recombinant sialyltransferase (D56ST3Gal Io rD56ST6Gal I), PNGase F( Roche) treatment of resialylated fetuin was carried out prior to click chemistry and western blot analysis. Resialylated glycoprotein (20 mg) was incubated in phosphate buffer (50 mm,2 1mL) and boiled (100 8C) for 10 min. After cooling, PNGase F( 1U)w as added and incubated 4h at 37 8C. After treatment, nine volumes of absolute ethanol were used to precipitate proteins.
Quantification of sialic acid (SiaNAl) transfer by micro-LC/ESI-MRM-MS 3 analysis: Sialyltransferase assays were performed essentially as described above with desialylated fetuin CMP-SiaNAl (200 mg) at the indicated concentration in cacodylate buffer (30 mL) supplemented with cell culture medium (6.5 mL) containing either D56ST3Gal Io rD56ST6Gal I(or mock). The reaction mixture was incubated for 6hat 37 8Ca nd stopped by addition of PTA( 1mL, 5% in 2 n HCl). Following overnight precipitation at À20 8C, resialylated proteins were washed three times with TCA (10 %). The glycosidic linkage between sialic acid and acceptor monosaccharide was hydrolyzed with TFA( 100 mL, 0.1 m), then the mixture was incubated for 2hat 80 8C, and dried in a5301 concentrator (Eppendorf). Derivation of sialic acid was performed for 2hat 50 8Ci nt he dark with DMB (32 mg), b-mercaptoethanol (0.5 m),N a 2 S 2 O 4 (9 mm),T FA (5 mm, 40 mL). Samples were stored at À20 8Cbefore analyzing.
Quantitative analyses were performed in positive ion mode on an amaZon speed ETD ion trap mass spectrometer (Bruker Daltonics) equipped with as tandard ESI source and controlled by Hystar software (ver.3 .2). The identification of MS 2 fragment ions was based on previously published analyses of DMB-coupled sialic acid by MS/MS. [36] DMB-coupled sialic acid separation was achieved on Prominence LC-20AB micro LC system (Shimadzu). Samples were diluted fivefold in formic acid (0.1 %), and dilutions (5 mL) were applied to aL una 3 mma nalytical column (C18 (2), 100 ,1 50 1mm; Phenomenex) with isocratic elution in acetonitrile/MeOH/ water (4:6:90, v/v/v)a t6 0mLmin
À1 .M ultiple reaction monitoring (MRM) of MS 3 was used for DMB-coupled Sia quantification (ion spray voltage 4500 V, dry gas flow rate 8Lmin Cell-based analyses:F ACS analysis and confocal microscopy: CHO-Lec2 cells (ATCC CRL-1736) were grown in DMEM with FCS (10 %) in a2 4-well plate to 70 %c onfluence. Cells were incubated for 2hat 37 8Cw ith CMP-Neu5Ac or CMP-SiaNAl (0-50 mm)i nc ellculture medium (200 mL) containing either D56ST3Gal Io r D56ST6Gal I( or no enzyme, mock). After cell washing with Dulbecco's phosphate-buffered saline (DPBS), cells were detached with EDTA( 5mm) and placed in a9 6-well plate. After centrifugation (260 g,5 min), fluorescein isothiocyanate-conjugated Sambucus nigra agglutinin (1 mg, 2mgmL
À1
,F ITC-SNA lectin;V ector Laboratories) in PBS/ BSA (1 %; 50 mL) was incubated with cells for 1h at 4 8C. Alternatively,o fb iotin-conjugated Maackia amurensis lectin II (1 mg, 1mgmL À1 , MAL II, Vector Laboratories) in aP BS/ BSA (1 %; 50 mL) was incubated with cells for 1h at 4 8C; after washing with PBS, FITC-conjugated streptavidin (0.1 mg, 1mg/mL, DyLight 488 Streptavidin;V ector Laboratories) was added to PBS/ BSA (1 %; 50 mL) and incubated for 1h at 4 8C. Finally,a fter three washing with PBS, cells were transferred to 5mLp olystyrene round-bottom tubes (BD Falcon), and fluorescence was quantified with aF ACSCalibur cytometer (Becton Dickinson).
For confocal microscopy,C HO Lec2 cells were grown on coverslips in DMEM with FCS (10 %) in a2 4-well plate to 70 %c onfluency. After DPBS washings, cells were incubated with cell culture medium (200 mL) containing either D56ST3Gal Io rD56ST6Gal I( or no enzyme, mock) and CMP-Neu5Ac or CMP-SiaNAl (20 mm)for 2h. Then cells were washed, fixed with paraformaldehyde (4 %) for 20 min, then incubated with PBS/ BSA (1 %) and saponin (0.075 %) for 1h at room temperature. Cells were incubated with SNA lectin (1.33 mg) in PBS/BSA (1 %; 50 mL) for 1h our at room temperature and washed three times with PBS. DAPI (1/200 in PBS/BSA (1 %)) was incubated with cells for 20 min at room temperature. Finally, after three washing with PBS, coverslips were mounted on glass slides with mounting medium (Dako). Fluorescence was detected through an inverted Zeiss 700 confocal microscope.
